Search
for

    Sort by

    Community Join

    990-1000 / 1000+ results

      community Sublingual topical minoxidil experience

      in Minoxidil  16 upvotes 4 years ago
      A user experienced severe side effects from using topical minoxidil sublingually, including muscle cramps, dizziness, and high potassium levels. They were advised to stop and seek medical help, emphasizing that topical minoxidil is not safe for ingestion due to its alcohol content.

      community RU58841 and Min - topical 50 mg each day

      in Progress Pictures  6 upvotes 1 year ago
      The conversation is about a person's hair improvement after 14.5 months using RU58841 and Minoxidil topically at 50 mg each day, with noticeable hairline improvement but incomplete crown area recovery. The person struggles to take good pictures of their crown area.

      community I want to attempt to use the MPC inhibitor JXL-069

      in Research/Science  14 upvotes 1 year ago
      The conversation discusses skepticism about group buys for hair loss treatments, highlighting issues with unverified chemicals and the risks involved. It suggests stabilizing with dutasteride and minoxidil, and considering a hair transplant instead of experimenting with untested products.

      community Best addition to oral fin and topical min after stopping RU?

      in Treatment  2 upvotes 2 months ago
      A 29-year-old male experienced hair thinning and used topical minoxidil, finasteride, and RU58841, but stopped RU58841 due to health concerns. He is considering adding topical dutasteride and switching to oral minoxidil to enhance regrowth, while others suggest using ketoconazole shampoo, microneedling, and lifestyle changes like diet and exercise.

      community GT20029 China Phase II Trial For AGA Reached Primary Endpoint

      in Research/Science  134 upvotes 2 years ago
      The GT20029 tincture, a topical androgen receptor degrader, showed significant hair growth and good safety in a China Phase II trial for male androgenetic alopecia (AGA), with the 1% dose twice weekly identified as optimal. The company plans to initiate Phase III trials in China and Phase II in the U.S., and the treatment also shows promise for acne.